Abstract
Almost all aspects of pharmacology involve dynamic processes. This is true whether one is concerned with drug absorption, distribution, metabolism and excretion, or whether one focuses on pharmacologic effects. It is necessary therefore to describe and to analyze these processes or effects in terms of their rates, rate constants or time course. A qualitative description is usually quite insufficient and seldom leads to adequate characterization of the effects of the body on drugs or of the effects of drugs on the body.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berman, M., Weiss, M.F.: SAAM manual, U. S. Public Health Service publication No. 1703, U. S. Government Printing Office, Washington 1967.
Bers, L.: Calculus, p. 413–416. New York: Holt, Rinehart and Winston 1969.
Bischoff, K.B., Dedrick, R.L.: Thiopental pharmacokinetics. J. pharm. Sci. 57, 1346–1351 (1968).
Control Data Corporation: Control Data Mimic Eeference Manual, Publication No. 44610400, 1968.
Dayton, P. G., Perel, J.M.: Physiological and physico-chemical bases of drug interactions in man. Ann. N. Y. Acad. Sci. 179, 67–87 (1971).
Dettli, L.: Multiple dose elimination kinetics and drug accumulation in patients with normal and with impaired kidney function. In: Advances in the biosciences, Vol. 5 (Raspé, G., Ed.), p. 39–54. New York: Pergamon Press 1970.
Dost, F.H.: Grundlagen der Pharmakokinetic, p. 155, 169, 190. Stuttgart: Thieme 1968.
Gibaldi, M.: Effect of mode of administration on drug distribution in a two-compartment open system. J. pharm. Sci. 58, 327–331 (1969).
Gibaldi, M., Boyes, R.N., Feldman, S.: Influence of first-pass effect on availability of drugs on oral administration. J. pharm. Sci. 60, 1338–1340 (1971a).
Gibaldi, M., Levy, G., Hayton, W.: Kinetics of the elimination and neuromuscular blocking effect of D-tubocurarine in man. Anesthesiology 36, 213–218 (1972).
Gibaldi, M., Levy, G., Weintraub, H.: Drug distribution and pharmacologic effects. Clin. Pharmacol. Ther. 12, 734–742 (1971b).
Gibaldi, M., Nagashima, R., Levy, G.: Relationship between drug concentration in plasma or serum and amount of drug in the body. J. pharm. Sci. 58, 193–197 (1969).
Gibaldi, M., Weintraub, H.: Some considerations as to the determination and significance of biologic half-life. J. pharm. Sci. 60, 624–626 (1971).
Jusko, W. J., Levy, G.: Pharmacokinetic evidence for saturable renal tubular reabsorption of riboflavin. J. pharm. Sci. 59, 765–772 (1970).
Keen, P.: Effect of binding to plasma proteins on the distribution, activity, and elimination of drugs. In: Handbook of Experimental Pharmacology, Vol. XXVIII (Brodie, B.B., Gillette, J.R., Eds.), Part I, Chapter 10. Berlin-Heidelberg-New York: Springer 1971.
Krüger-Thiemer, E., Levine, R.R.: The solution of pharmacological problems with computers. Part 8: Non first-order models of drug metabolism. Arzneimittel-Forsch. 18, 1575–1579 (1968).
Levy, G.: Pharmacokinetics of salicylate elimination in man. J. pharm. Sci. 54, 959–967 (1965).
Levy, G.: Kinetics of pharmacologic effects. Clin. Pharmacol. Ther. 7, 362–372 (1966).
Levy, G.: Dose-dependent effects in pharmacokinetics. In: Importance of fundamental principles in drug evaluation (Tedesohi, D.H., Tedesohi, R.E., Eds.), p. 141–172. New York: Raven Press 1968.
Levy, G.: Effect of protein binding on the distribution and metabolism of a highly plasma protein bound drug (bishydroxycoumarin). In: Proc. Fourth Int. Congr. on Pharmacol., Vol. IV, p. 134–143. Basel: Schwabe 1970a.
Levy, G.: Pharmacokinetics of succinylcholine in newborns. Anesthesiology 32, 551–552 (1970b).
Levy, G.: Correlation between drug concentration and drug response in man: pharmacokinetic considerations. In: Proc. Fifth Int. Congr. Pharmacol., Vol. 2. Basel: Karger 1973.
Levy, G., Gibaldi, M.: Pharmacokinetics of drug action. Ann. Rev. Pharmacol. 12, 85–98 (1972).
Levy, G. Tsuchiya, T.: Salicylate accumulation kinetics in man. New Engl. J. Med. 287, 430–432 (1972).
Levy, G., Tsuchiya, T., Amsel, L.P.: Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin. Pharmacol. Ther. 13, 258–268 (1972).
Loo, J.C.K., Riegelman, S.: New method for calculating the intrinsic absorption rate of drugs. J. pharm. Sci. 57, 918–928 (1968).
Loo, J. C.K., Riegelman, S.: Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion. J. pharm. Sci. 59, 53–55 (1970).
Lundquist, F., Wolthers, H.: The kinetics of alcohol elimination in man. Acta pharmacol. (Kbh.) 14, 265–289 (1958).
Marquardt, D.W.: DPE-NLIN, Share General Library Program No. 7–1354, 1964.
Mayersohn, M., Gibaldi, M.: Mathematical methods in pharmacokinetics. II. Solution of the two-compartment open model. Amer. J. pharm. Educ. 35, 19–28 (1971).
Metzler, C.M.: NONLIN, technical report No. 7292/69/7293/005. Kalamazoo: The Upjohn Company 1969.
Nagashima, R., Levy, G., O’Reilly, R.A.: Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartment model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination. J. pharm. Sci. 57, 1888–1895 (1968).
Nagashima, R., O’Reilly, R.A., Levy, G.: Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin. Pharmacol. Ther. 10, 22–35 (1969).
Nelson, E., O’Reilly, I.: Kinetics of sulfisoxazole acetylation and excretion in humans. J. Pharmacol, exper. Ther. 129, 368–372 (1960).
O’Reilly, R.A., Aggeler, P.M., Leong, L.S.: Studies on the coumarin anticoagulant drugs: a comparison of the pharmacodynamics of dicumarol and warfarin in man. Thrombos. Diathes. haemorrh. 11, 1–22 (1964).
Perrier, D., Ashley, J. J., Levy, G.: Effect of product inhibition on kinetics of drug elimination. J. Pharmacokin. Biopharm. 1, 231–242 (1973).
Rowland, M., Benet, L.Z., Riegelman, S.: Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics. J. pharm. Sci. 59, 364 – 367 (1970).
Tsuchiya, T., Levy, G.: Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics. J. pharm. Sci. 61, 541–544 (1972).
Wagner, J.G.: Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man. J. theor. Biol. 20, 173–201 (1968).
Wagner, J. G.: Biopharmaceutics and relevant pharmacokinetics, Hamilton: Drug Intelligence Publications, Chapter 40, 1971.
Wagner, J. G.: Personal communication 1972.
Wagner, J. G., Nelson, E.: Percent absorbed time plots derived from blood level and/or urinary excretion data. J. pharm. Sci. 52, 610–611 (1963).
Wagner, J.G., Northam, J.L, Alway, C.D., Carpenter, O.S.: Blood levels of drug at the equilibrium state after multiple dosing. Nature (Lond.) 207, 1301–1302 (1965).
Wagner, J.G., Novak, E., Leslie, L.G., Metzler, C.M.: Absorption, distribution, and elimination of spectinomycin dihydrochloride in man. Int. J. clin. Pharmacol. 1, 261–285 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Levy, G., Gibaldi, M. (1975). Pharmacokinetics. In: Gillette, J.R., Mitchell, J.R. (eds) Concepts in Biochemical Pharmacology. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 28 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46314-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-46314-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46316-7
Online ISBN: 978-3-642-46314-3
eBook Packages: Springer Book Archive